Live Breaking News & Updates on நோய் விழிப்புணர்வு பிரச்சாரம்
Stay updated with breaking news from நோய் விழிப்புணர்வு பிரச்சாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights Company well positioned for PDUFA date of April 29, 2021 and the potential launch of tenapanor News provided by Share this article Share this article FREMONT, Calif. and WALTHAM, Mass., March 8, 2021 /PRNewswire/ Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today reported business highlights and financial results for the fourth quarter and full year ended December 31, 2020. The stage is set for an exciting year for Ardelyx in 2021 said Mike Raab, president and chief executive officer at Ardelyx. With our PDUFA date of April 29 rapidly approaching, we are well positioned and well prepared to commercialize tenapanor upon potential FDA approval of the first and only phosphate absorption inhibitor for the control of serum phos ....
Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.